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a b s t r a c t
The importance of the gutebrain axis in regulating stress-related responses has long been appreciated.
More recently, the microbiota has emerged as a key player in the control of this axis, especially during
conditions of stress provoked by real or perceived homeostatic challenge. Diet is one of the most
important modifying factors of the microbiota-gut-brain axis. The routes of communication between the
microbiota and brain are slowly being unravelled, and include the vagus nerve, gut hormone signaling,
the immune system, tryptophan metabolism, and microbial metabolites such as short chain fatty acids.
The importance of the early life gut microbiota in shaping later health outcomes also is emerging. Results
from preclinical studies indicate that alterations of the early microbial composition by way of antibiotic
exposure, lack of breastfeeding, birth by Caesarean section, infection, stress exposure, and other envi-
ronmental inﬂuences - coupled with the inﬂuence of host genetics - can result in long-term modulation
of stress-related physiology and behaviour. The gut microbiota has been implicated in a variety of stress-
related conditions including anxiety, depression and irritable bowel syndrome, although this is largely
based on animal studies or correlative analysis in patient populations. Additional research in humans is
sorely needed to reveal the relative impact and causal contribution of the microbiome to stress-related
disorders. In this regard, the concept of psychobiotics is being developed and reﬁned to encompass
methods of targeting the microbiota in order to positively impact mental health outcomes. At the 2016
Neurobiology of Stress Workshop in Newport Beach, CA, a group of experts presented the symposium
“The Microbiome: Development, Stress, and Disease”. This report summarizes and builds upon some of
the key concepts in that symposium within the context of how microbiota might inﬂuence the neuro-
biology of stress.
© 2017 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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1. Introduction
The concept of the gut inﬂuencing brain and behaviour, and
vice-versa, has perhaps been best appreciated and studied as it
relates to the cephalic (preparatory) phase of digestion, visceral
pain and malaise, and the ability of emotional stress to disrupt
digestive functions. Nonetheless, despite wide integration of the
“gut-brain” concept into our everyday vernacular (e.g., gut feelings,
gut-wrenching, gut instinct, gutted, gutsy, it takes guts, butterﬂies
in one's stomach), neuroscientists have only recently developed
adequate tools with which to reveal the bi-directional links be-
tween gut physiology and brain function, and to determine how
these links operate under normal and stressful conditions. At the
2016 Neurobiology of Stress Workshop in Newport Beach, CA, a
group of experts presented the symposium “The Microbiome:
Development, Stress, and Disease”. This report summarizes and
expands upon some of the key points from this symposium,
focused on current understanding of how microbiota inﬂuence the
neurobiology of stress.
The complex and multifaceted system of gut-brain communi-
cation not only ensures proper maintenance and coordination of
gastrointestinal functions to support behaviour and physiological
processes, but also permits feedback from the gut to exert profound
effects on mood, motivated behaviour, and higher cognitive func-
tions. The linkage between gut functions on the one hand and
emotional and cognitive processes on the other is afforded through
afferent and efferent neural projection pathways, bi-directional
neuroendocrine signaling, immune activation and signaling from
gut to brain, altered intestinal permeability, modulation of enteric
sensory-motor reﬂexes, and entero endocrine signaling (Mayer
et al., 2014a; Sherwin et al., 2016). Gut microbiota have emerged
as a critical component potentially affecting all of these neuro-
immuno-endocrine pathways (Carabotti et al., 2015; Bailey, 2014).
For example, even short-term exposure to stress can impact the
microbiota community proﬁle by altering the relative proportions
of the main microbiota phyla (Galley et al., 2014), and experimental
alteration of gut microbiota inﬂuences stress responsiveness,
anxiety-like behaviour, and the set point for activation of the
neuroendocrine hypothalamic-pituitary-adrenal (HPA) stress axis
(Carabotti et al., 2015; Golubeva et al., 2015; De Palma et al., 2015;
Moussaoui et al., 1610; Crumeyrolle-Arias et al., 2014). Disease-
related animal models such as mild and chronic social defeat
stress also lead to signiﬁcant shifts in cecal and fecal microbiota
composition; these changes are associated with alterations in
microbiota-related metabolites and immune signaling pathways
suggesting that these systems may be important in stress-related
conditions including depression (Bharwani et al., 2016; Aoki-
Yoshida et al., 2016).
2. The gut microbiome
Within the past decade it has become clear that the gut
microbiota is a key regulator of the gut-brain axis. The gut is home
to a diverse array of trillions of microbes, mainly bacteria, but also
archaea, yeasts, helminth parasites, viruses, and protozoa
(Lankelma et al., 2015; Eckburg et al., 2005; Gaci et al., 2014;
Scarpellini et al., 2015; Williamson et al., 2016). The bacterial gut
microbiome is largely deﬁned by two dominant phylotypes, Bac-
teroidetes and Firmicutes, with Proteobacteria, Actinobacteria,
Fusobacteria, and Verrucomicrobia phyla present in relatively low
abundance (Lankelma et al., 2015; Qin et al., 2010). Although the
ratio of microbial to human cells has been recently revised down-
ward (Sender et al., 2016), it is evident that microbial cells
outnumber human cells. The total weight of these gut microbes is
1e2 kg, similar to the weight of the human brain (Stilling et al.,
2014). Microbiota and their host organisms co-evolved and are
mutually co-dependent for survival, and mammals have never
existed without microbes, except in laboratory situations
(Bordenstein and Theis, 2015).
In humans and other mammals, colonization of the infant gut is
thought to largely begin at birth, when delivery through the birth
canal exposes the infant to its mother's vaginal microbiota, thereby
initiating a critical maternal inﬂuence over the offspring's lifelong
microbial signature (Backhed et al., 2015; Collado et al., 2012;
Donnet-Hughes et al., 2010). Advances in sequencing technolo-
gies are revealing that the early developmental microbiota signa-
ture inﬂuences almost every aspect of the organism's physiology,
throughout its life. The role of microbiota composition as a sus-
ceptibility factor for various stressful insults, especially at key
neurodevelopmental windows, is rapidly emerging (Borre et al.,
2014), and there is growing evidence that targeted manipulations
of the microbiota might confer protection to the brain to ameliorate
the negative effects of stress during vulnerable developmental
periods.
3. Gut microbiota and stress-related behaviours
Several lines of evidence support the suggestion that gut
microbiota inﬂuence stress-related behaviours, including those
relevant to anxiety and depression. Work using germ-free (GF)
mice (i.e., delivered surgically and raised in sterile isolators with no
microbial exposure) demonstrates a link between microbiota and
anxiety-like behaviour (Neufeld et al., 2011; Diaz Heijtz et al., 2011;
Clarke et al., 2013). In particular, reduced anxiety-like behaviour in
GF mice was shown in the light-dark box test and in the elevated
plus maze (see (Luczynski et al., 2016a) for review). On the other
hand, GF rats display the opposite phenotype, and are characterized
by increased anxiety-like behaviour (Crumeyrolle-Arias et al.,
2014). Interestingly, the transfer of stress-prone Balb/C microbiota
to GF Swiss Webster (SW) mice has been shown to increase
anxiety-related behaviour compared to normal SW mice, while
transfer of SW microbiota to GF Balb/C mice reduced anxiety-
related behaviour compared to normal Balb/C mice suggesting a
direct role for microbiota composition in behaviour (Bercik et al.,
2011a). Further, monocolonization of GF mice with Lactobacillus
plantarum PS128 increased locomotor activity in comparison to
control GF mice, a behavioural change that was associated with
increased levels of dopamine, serotonin and their metabolites in
the striatum (Liu et al., 2016a). Furthermore, antibiotic treatment
during adolescence in mice altered microbiota composition and
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diversity with concomitant reduction in anxiety-like behaviour
(Desbonnet et al., 2015). Interestingly, the reduced anxiety-like
behaviour was accompanied by cognitive deﬁcits, reduced levels
of hippocampal brain-derived neurotrophic factor (BDNF) mRNA,
and reduced levels of oxytocin and vasopressin in the hypothala-
mus (Desbonnet et al., 2015).
4. The microbiome and central stress effects
Individual differences in life-long stress responsiveness and
susceptibility to stress-related disorders have been linked both to
genetic and environmental factors, particularly early-life exposures
that can alter the developmental assembly and function of central
neural circuits. Intriguingly, it has become increasingly clear that
bacteria are required for normal brain development (Neufeld et al.,
2011; Diaz Heijtz et al., 2011; Clarke et al., 2013; Bercik et al., 2011a;
Hsiao et al., 2013; Stilling et al., 2015) as well as brain function in
adulthood. Indeed, key processes associated with neuroplasticity in
the adult brain such as neurogenesis (Ogbonnaya et al., 2015) and
microglia activation (Erny et al., 2015) have been shown to be
regulated by the microbiota. Findings such as these have contrib-
uted to a paradigm shift in neuroscience and psychiatry (Mayer
et al., 2014b; Cryan and Dinan, 2012), such that the early devel-
opment and later function of the brain may be modiﬁed by tar-
geting the microbiome.
Evidence for a crucial role for the microbiota in regulating
stress-related changes in physiology, behaviour and brain function
has emerged primarily from animal studies. A very important dis-
covery was made in 2004, when GF mice were found to have an
exaggerated HPA axis response to stress, which could be reversed
by colonization with a speciﬁc Biﬁdobacteria species (Sudo et al.,
2004). Results from subsequent studies have continued to sup-
port a connection between gut microbiota and stress responsive-
ness, including reports that stress exposure early in life or in
adulthood can change the organism's microbiota composition, and
that microbial populations can shape an organism's stress
responsiveness (Golubeva et al., 2015; De Palma et al., 2015;
Bharwani et al., 2016; O'Mahony et al., 2009; Bailey et al., 2011;
Jasarevic et al., 2015). Recently, investigators have used fecal
microbiota transplantation approaches to demonstrate that stress-
related microbiota composition play a causal role in behavioural
changes. In one example, investigators showed that transplanting
themicrobiota from stressor-exposed conventional mice to GFmice
resulted in exaggerated inﬂammatory responses to Citrobacter
rodentium infection (Willing et al., 2011). A link between disease-
related microbiota and behaviour was also recently demon-
strated, where fecal microbiota transplantation from depressed
patients to microbiota-depleted rats increased anhedonia and
anxiety-like behaviours (Kelly et al., 2016).
A key question in the ﬁeld is whether treatments targeting the
microbiota-brain axis may have therapeutic beneﬁts in stress-
related disorders. To this end, several studies have shown that di-
ets that modify the microbiota, prebiotics, and probiotics can
reduced stress-related behaviour and HPA activation. For example,
dietary supplementation with the n-3 polyunsaturated fatty acid,
docosahexaenoic acid (DHA), in socially isolated mice reduces
anxiety and depressive-like behaviours inmale but not femalemice
(Davis et al., 2016). These behavioural effects were associated with
male-speciﬁc changes in microbiota composition suggesting that
these protective effects were mediated by microbiota (Davis et al.,
2016). Similarly, long-term supplementation with eicosapentae-
noic acid (EPA)/DHA mixture normalized the microbiota proﬁle in
rats exposed to early life stress and attenuated stress reactivity
(Pusceddu et al., 2015). Prebiotics are non-digestible food in-
gredients that promote growth of commensal bacteria. Mice
exposed to a social disruption stressor displayed increased anxiety-
like behaviour and a reduced number of immature neurons in the
hippocampus, whereas stressed mice that received human milk
oligosaccharides 3'sialyllactose or 6'sialyllactose for 2 weeks prior
to stress were protected from stress-related changes in behaviour
and CNS effects (Tarr et al., 2015). Interestingly, prebiotic admin-
istration of bimuno-galactooligosaccharides (B-GOS) reduced sali-
vary cortisol awakening response in healthy people (Schmidt et al.,
2015). The reversal of stress effects by probiotics has also been
demonstrated. For example, administration of Lactobacillus helve-
ticus NS8 to Sprague Dawley rats improved stress-induced behav-
iour deﬁcits and attenuated the stress-induced levels of
corticosterone (Liang et al., 2015). Similarly, administration of
L. heleveticus R0052 and Biﬁdobacterium longum R0175 prevented
stress-induced changes in neurogenesis, barrier integrity, and
stress-reactivity (Ait-Belgnaoui et al., 2012).
As mentioned above, the experimental use of GF mice has been
instrumental in revealing the impact of microbiota on early brain
development (Luczynski et al., 2016a; Gareau, 2014; Sampson and
Mazmanian, 2015). A lack of microbes impacts multiple stress-
related neurotransmitter systems, across multiple brain regions.
Using a genome-wide transcriptomic approach to compare normal
control mice to GF mice, Diaz Heijtz and colleagues demonstrated
that the GF condition was accompanied by upregulation of many
genes associated with a variety of plasticity and metabolic path-
ways including synaptic long-term potentiation, steroid hormone
metabolism, and cyclic adenosine 5-phosphate-mediated signaling
(Diaz Heijtz et al., 2011). The functional consequences of this altered
gene expression is evident in many brain regions. For example, GF
mice display increased expression of myelin-associated genes
within the prefrontal cortex, accompanied by hypermyelination
within the same brain region (Hoban et al., 2016). Similar ﬁndings
have been reported within the prefrontal cortex of mice treated
with antibiotics in order to deplete the microbiome in adulthood
(Gacias et al., 2016).
Gene expression within the hippocampus also is markedly
different in GF mice compared to normal controls. The hippocam-
pus exerts strong control over the HPA stress axis, and GF mice are
characterized by markedly increased hippocampal 5-HT concen-
trations (Clarke et al., 2013), accompanied by decreased 5-HT1A
receptor gene expression in the dentate gyrus in female (but not
male) GF mice (Neufeld et al., 2011). Intriguingly, other CNS alter-
ations in GFmice also are sex-dependent; e.g., altered expression of
BDNF has been documented only in male GF mice (Clarke et al.,
2013). BDNF is an important plasticity-related protein that pro-
motes neuronal growth, development and survival, with key roles
in learning, memory andmood regulation. BDNF gene expression is
lower in the cortex and amygdala in male GF mice compared with
controls (Diaz Heijtz et al., 2011), whereas hippocampal BDNF
levels in GF mice have been reported to either increase (Neufeld
et al., 2011) or decrease (Diaz Heijtz et al., 2011; Clarke et al.,
2013; Sudo et al., 2004). Hippocampal neurogenesis also is regu-
lated by the microbiome, such that GF mice exhibit increased
neurogenesis in the dorsal hippocampus (Ogbonnaya et al., 2015).
Adult hippocampal neurogenesis plays a critical role not only in
modulating learning and memory, but also in mediating behav-
ioural responses to stress and antidepressant drugs (O'Leary and
Cryan, 2014). Although adult GF mice display modest increases in
hippocampal volume, ventral hippocampal pyramidal neurons and
dentate granule cells are characterized by reduced dendritic
branching, with pyramidal neurons displaying fewer stubby and
mushroom spines (Luczynski et al., 2016b). Postweaning microbial
colonization of GF mice failed to reverse the changes in adult hip-
pocampal neurogenesis, suggesting that there is a critical pre-
weaning developmental window during which the microbiota
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shapes life-long capacity for hippocampal neurogenesis
(Ogbonnaya et al., 2015). Conversely, hippocampal neurogenesis is
reduced in normal adult mice after they are exposed to an antibiotic
regimen to deplete microbiota, an effect that is reversible by ex-
ercise or administration of a probiotic cocktail (Mohle et al., 2016).
The microbiome also affects the structure and function of the
amygdala, another key stress-related brain region. The amygdala is
critical for emotional learning and social behaviour, and is critical
for the gating of behavioural and physiological responses to
stressful stimuli, especially those that trigger anxiety and/or fear
(Stilling et al., 2015; LeDoux, 2007). Altered amygdalar processes
are associated with a variety of neuropsychiatric disorders, ranging
from autism spectrum (Schumann and Amaral, 2006; Mosconi
et al., 2009) to anxiety disorders (LeDoux, 2007; Janak and Tye,
2015). GF mice (on a SW background) display increased amygdala
volume, accompanied by dendritic hypertrophy within the baso-
lateral amygdala (BLA). Accordingly, BLA pyramidal neurons are
characterized by increased numbers of thin, stubby and mushroom
spines in GF mice compared to normal controls (Luczynski et al.,
2016b). RNA sequencing studies have revealed signiﬁcant differ-
ences in differential gene expression, exon usage, and RNA-editing
within the amygdala. The amygdala of GF mice displays increased
expression of immediate early response genes such as Fos, Fosb,
Egr2 and Nr4a1, along with increased signaling of the transcription
factor CREB (Stilling et al., 2015). Differential amygdalar expression
and recoding of genes involved in neuronal plasticity, metabolism,
neurotransmission, and morphology also were identiﬁed in GF
mice. A signiﬁcant downregulation of immune system-related
genes was noted in GF mice (Stilling et al., 2015), consistent with
a reportedly underdeveloped immune and brain microglia systems
(Erny et al., 2015). Indeed, the immune system may provide a
crucial link for microbiota effects on brain physiology and behav-
iour, perhaps via the recently discovered lymphatic branches
within the central nervous system (Louveau et al., 2015).
Although GF mice have been instrumental in advancing all as-
pects of microbiome research, including microbiome-to-brain
signaling (Luczynski et al., 2016a; Grover and Kashyap, 2014), the
experimental GF mice model has many drawbacks that limit its
utility for clinical translation (Nguyen et al., 2015; Al-Asmakh and
Zadjali, 2015; Arrieta and Finlay, 2014). Nevertheless, GF mice
provide a platform onwhich to explore the role of bacteria on early
host development and function (Nguyen et al., 2015; Al-Asmakh
and Zadjali, 2015; Faith et al., 2010; Arrieta et al., 2014). Antibiotic
treatment is an alternative approach that can bypass the perinatal
developmental period. Antiobiotic treatment in adult mice alters
BDNF protein levels in both the amygdala and hippocampus (Bercik
et al., 2011a). When administered during postnatal development,
antibiotics promote visceral hypersensitivity in adult male rats
without affecting anxiety, cognitive, immune or stress-related re-
sponses (O'Mahony et al., 2014). In this model, visceral hypersen-
sitivity was paralleled by speciﬁc changes in the spinal expression
of pain-associated genes (transient receptor potential cation
channel subfamily V member 1, the a-2A adrenergic receptor and
cholecystokinin B receptor) (O'Mahony et al., 2014). Conversely,
antibiotic depletion of microbiota later in life (i.e., in adolescent
mice after weaning) led to reduced anxiety coupled with cognitive
deﬁcits measured in adulthood (Desbonnet et al., 2015). Altered
tryptophan metabolism also was observed in the same animals,
along with signiﬁcantly reduced BDNF, oxytocin and vasopressin
gene expression (Desbonnet et al., 2015). More recently, antibiotic
depletion in adult rats reportedly has been reported to have a
limited impact on stress, anxiety or HPA axis function, but increases
depressive-like behaviours, reduces visceral pain responses, and
impairs cognition (Hoban et al., 2016). Together these results
highlight the importance of microbiome integrity at key
developmental windows.
5. Mechanisms of communication from gut microbiota to
brain
The precise role played by the microbiota in gut-brain-gut
signaling pathways remains to be elucidated. Hindering our ef-
forts is the limited current state of knowledge regarding the iden-
tity and function of the gut's vast and diverse microbial
composition. However, advances in the ﬁeld of metagenomics
promise to address this concern (Clarke et al., 2012; Fraher et al.,
2012). For example, a recent paper (Matsumoto et al., 2013)
examining the role of gut microbiota in cerebral metabolism re-
ports that GF mice have an altered metabolic proﬁle compared to
their conventionally colonised counterparts, with 10 of these me-
tabolites thought to be speciﬁcally involved in brain function.
However, the key question remains: through what mechanisms do
the gut microbiota inﬂuence the CNS, and vice-versa?
A complex communication network exists between the gut and
the CNS, which includes the enteric nervous system (ENS), sym-
pathetic and parasympathetic branches of the autonomic nervous
system (ANS), neuroendocrine signaling pathways, and neuro-
immune systems (Grenham et al., 2011). Afferent spinal and vagal
sensory neurons carry visceral feedback from the gut to the thoracic
and upper lumbar spinal cord and to the nucleus of the solitary
tract within the caudal brainstem, engaging polysynaptic inputs to
higher brain regions, including the hypothalamus and limbic
forebrain. Bi-directional control is provided by descending pre-
autonomic neural projections from the cingulate and insular
cortices, amygdala, bed nucleus of the stria terminalis, and hypo-
thalamus, all of which are positioned to alter vagal and spinal
autonomic outﬂow to the gut (O'Mahony et al., 2011). Collectively,
the microbiotaebrainegut axis is thought to communicate not only
via these neural routes, but also via humoral signaling molecules
and hormonal components. Together, this intricate network exerts
effects which alter both GI and brain function (Mayer et al., 2015;
Rhee et al., 2009).
5.1. Neural pathways
The gut is innervated by the ENS, a complex peripheral neural
circuit embedded within the gut wall comprising sensory neurons,
motor neurons, and interneurons. While the ENS is capable of
independently regulating basic gastrointestinal (GI) functions (i.e.,
motility, mucous secretion, and blood ﬂow), central control of gut
functions is provided by vagal and, to a lesser extent, spinal motor
inputs that serve to coordinate gut functions with the general ho-
meostatic state of the organism (Mertz, 2003). This central control
over the ENS is important for adaptive gut responses during
stressful events that signal homeostatic threat to the organism. The
vagus nerve has been proposed to serve as the most important
neural pathway for bidirectional communication between gut mi-
crobes and the brain (Forsythe et al., 2012, 2014; Goehler, 2006). For
example, an intact vagal nerve appears necessary for several effects
induced by two separate probiotic strains in rodents (Perez-Burgos
et al., 2014). Speciﬁcally, chronic treatment with Lactobacillus
rhamnosus (JB-1) led to region-dependent alterations in central
GABA receptor expression, accompanied by reduced anxiety- and
depression-like behaviour and attenuation of stress-induced
corticosterone response; these effects required an intact vagus
nerve (Bravo et al., 2011). Similarly, in a colitis model, the anxiolytic
effect of Biﬁdobacterium longum was absent in vagotomised mice
(Bercik et al., 2011b). In contrast to effects mediated by probiotics
(i.e., microbial supplementation), changes in the microbial ecology
as a consequence of antibiotic treatment in mice did not depend on
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vagal nerve integrity (Bercik et al., 2011a). Thus, additional
signaling pathways are likely involved in microbiotaebrainegut
communication (Barrett et al., 2012).
In a subset of ENS neurons (i.e., sensory after-hyperpolarization
neurons), the probiotic Lactobacillus reuteri was found to increase
excitability and the number of action potentials per depolarizing
pulse, to decrease calcium-dependent potassium channel opening,
and to decrease the slow after-hyperpolarization. Thus, L. reuteri
appears to target an ion channel in enteric sensory neurons which
may mediate its effects on gut motility and pain perception (Kunze
et al., 2009). More recently, the electrophysiological properties of
myenteric neurons were found to be altered in GF mice, in which
myenteric sensory neurons displayed reduced excitability that was
restored after colonization with normal gut microbiota (McVey
Neufeld et al., 2013).
5.2. Enteroendocrine signaling
A functional microbiotaeneurohumoral relationship is estab-
lished during early microbial colonization of the gut. A multitude of
biologically active peptides are present at numerous locations
throughout the brainegut axis, and have a broad array of functions
that include not only gut motility and secretion, but also regulation
of emotional affect and stress resilience. Bacterial by-products that
come into contact with the gut epithelium are known to stimulate
enteroendocrine cells (EECs) to produce several neuropeptides
such as peptide YY, neuropeptide Y (NPY), cholecystokinin,
glucagon-like peptide-1 and -2, and substance P (Cani et al., 2013;
Cani and Knauf, 2016). After their secretion by EECs, these neuro-
peptides presumably diffuse throughout the lamina propria, which
is occupied by a variety of immune cells, en route to the blood-
stream and/or local receptor-mediated effects on intrinsic ENS
neurons or extrinsic neural innervation (e.g., vagal sensory affer-
ents) (Holzer and Farzi, 2014). However, it still is unknownwhether
any of these EEC peptides are necessary or sufﬁcient for bidirec-
tional communication between the microbiota and CNS. A different
type of potential signaling pathway was revealed more recently
(Bohorquez et al., 2015), demonstrating direct paracrine commu-
nication between EECs and neurons innervating the small intestine
and colon (Bohorquez et al., 2015). This newly-identiﬁed neuro-
epithelial circuit may act as a sensory channel for signaling from
luminal gut microbiota to the CNS via the ENS, and vice versa. The
physical innervation of sensory EECs suggests the presence of an
accurate temporal transfer of sensory signals originating in the gut
lumen with a real-time modulatory feedback to EECs.
5.3. Serotonin & tryptophan metabolism
Serotonin [5-hydroxytryptamine (5-HT)] is a biogenic amine
that functions as a neurotransmitter within the brain and also
within the ENS. Indeed, approximately 95% of 5-HTwithin the body
is produced by gut mucosal enterochromafﬁn cells and ENS neu-
rons. Peripherally, 5-HT is involved in the regulation of GI secretion,
motility (smooth muscle contraction and relaxation), and pain
perception (Costedio et al., 2007; McLean et al., 2007), whereas in
the brain 5-HT signaling pathways are implicated in regulating
mood and cognition (Wrase et al., 2006). Thus, dysfunctional 5-HT
signaling may underlie pathological symptoms related to both GI
and mood disorders, and may also contribute to the high co-
morbidity of these disorders (Folks, 2004). Supporting this idea,
drugs that modulate serotonergic neurotransmission, such as tri-
cyclic antidepressants and speciﬁc serotonin reuptake inhibitors,
also have efﬁcacy for treating irritable bowel syndrome (IBS) and
other GI disorders (Creed, 2006; Gershon and Tack, 2007). It also
recently has been shown that the microbiota can regulate 5-HT
synthesis in the gut. Speciﬁcally, indigenous spore-forming bacte-
ria from the mouse and human microbiota have been shown to
promote 5-HT biosynthesis from colonic enterochromafﬁn cells
(Yano et al., 2015).
Serotonin synthesis is crucially dependent on the availability of
tryptophan, an essential amino acid which must be supplied by the
diet. Clinical depression is associated with reduced plasma tryp-
tophan concentrations and enhanced enzyme activity (Myint et al.,
2007). Interestingly, the early life absence of microbiota in GF mice
leads to increased plasma tryptophan concentrations and increased
hippocampal levels of 5-HT in adulthood (Clarke et al., 2013). These
effects are normalized following the introduction of bacteria to GF
mice post-weaning, with the probiotic B. infantis reported to affect
tryptophan metabolism (Desbonnet et al., 2008). Therefore, gut
microbiota may play a crucial role in tryptophan availability and
metabolism to consequently impact central 5-HT concentrations.
Although the speciﬁc mechanisms underlying this putative
modulatory interaction are unknown, they are potentially medi-
ated indirectly through an immune-related mechanism linked to
microbial colonization (El Aidy et al., 2012).
5.4. Immune signaling
The immune system plays an important intermediary role in the
dynamic equilibrium that exists between the brain and the gut
(Bengmark, 2013). The HPA axis, ANS and ENS all directly interact
with the immune system (Bateman et al., 1989; Genton and Kudsk,
2003; Hori et al., 1995; Leonard, 2006; Nance and Sanders, 2007),
and the gut itself is an important immune organ that provides a
vital defensive barrier between externally-derived pathogens and
the internal biological environment. Gut-associated lymphoid tis-
sues form the largest immune organ of the human body,
comprising more than 70% of the total immune system (Vighi et al.,
2008). A direct link between infection and brain function has long
been known, mainly through the observation that syphilis and
Lyme disease often promote psychiatric symptoms (Biesiada et al.,
2012). Research using animal models has clearly demonstrated that
infectious microorganisms affect behavioural measures through
activation of the immune signaling pathways from body to the
brain. For example, the pathogenic bacteria Campylobacter jejuni,
when administered to mice at subclinical doses, results in anxiety-
like behaviour (Lyte et al., 1998). Peripheral administration of pro-
inﬂammatory cytokines in rodents induces a variety of depressive-
like behaviours, including sleep disturbances, reduced appetite,
and suppression of exploratory behaviour, collectively referred to
as sickness behaviours (Bilbo and Schwarz, 2012). Although gut
microbes are known to contribute to the maturation and fortiﬁca-
tion of the immune response, the molecular basis of these contri-
butions is not yet clear. The immunoregulatory effects of probiotic
microorganisms have been proposed to occur through the gener-
ation of T regulatory cell populations and the synthesis and secre-
tion of the anti-inﬂammatory cytokine, IL-10 (Dinan et al., 2013). In
support of this, oral consumption of Biﬁdobacterium infantis 35624
in humans is associated with enhanced IL-10 expression in pe-
ripheral blood (Bilbo and Schwarz, 2012). Furthermore, feeding of a
commensal bacteria to GFmice promotes Treg production and IL-10
synthesis (Macpherson and Uhr, 2002). Therefore, the balance of
gut microbes may closely regulate host inﬂammatory responses.
Disturbances to this microbial balance, particularly in early life
(O'Mahony et al., 2009), may promote a chronic inﬂammatory state
that can lead to maladaptive changes in mood and behaviour,
including increased responsiveness to stress and increased inci-
dence of stress-related disorders.
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6. Stress-related disorders and the microbiomeegutebrain
axis
6.1. Major depressive disorder (MDD)
One of the principal mechanisms proposed to underlie a gut-
brain link in stress-related disorders is via disrupted gut barrier
function commonly known as the “leaky gut” phenomenon (Maes
et al., 2009), which is proposed to contribute to MDD. The pro-
posed mechanism of action is that the epithelial barrier of the GI
tract becomes compromised as a result of psychological or organic
stress, leading to increased intestinal permeability and subsequent
translocation of gram-negative bacteria across the mucosal lining
to access immune cells and the ENS (Gareau et al., 2008). Bacterial
translocation leads to activation of an immune response charac-
terized by increased production of inﬂammatory mediators such as
IL-6 and IFNg. In mice, pre-treatment with the probiotic
L. farciminis attenuates the ability of acute restraint stress to in-
crease intestinal permeability and HPA axis responsivity (Ait-
Belgnaoui et al., 2012). In further support of the “leaky gut” hy-
pothesis, serum concentrations of IgM and IgA against LPS of
enterobacteria is signiﬁcantly higher in MDD patients compared to
healthy controls (Maes and Leunis, 2008). This would suggest that
bacterial translocation from the gut is increased in MDD, and the
resulting inﬂammatory response may contribute to the mood dis-
order. Currently, however, clinical evidence linking MDD with al-
terations in the gut microbiota is relatively sparse. Naseribafrouei
and colleagues failed to identify any differences in terms of mi-
crobial diversity within faecal samples obtained fromMDD patients
and controls, although the levels of Bacteroidetes were lower in
MDD patients (Naseribafrouei et al., 2014). Conversely, Jiang and
colleagues reported increased diversity (using the Shannon index)
in the composition of faecal sample microbiota in MDD patients
compared to healthy controls, including increased diversity in the
Bacteroidetes and Proteobacteria (which include the LPS-
expressing Enterobacteriaceae) phyla, countered by a concomi-
tant reduction in the diversity of Firmicutes (Jiang et al., 2015). The
basis for conﬂicting results between these two studies is unclear,
but may stem from the different control groups that were used (i.e.,
outpatients from a neurological unit versus healthy control sub-
jects). More recently, a decreased gut microbial richness and di-
versity was observed in depressed patients (Kelly et al., 1016).
Animal models have improved our understanding of how the
gut microbiota may inﬂuence stress-related disorders, including
depressive-like behaviours. Maternal separation is frequently used
as a model of early life stress that provokes an adult depressive and
anxiety-like phenotype, along with alterations in monoamine
turnover, immune function and HPA axis activation (O'Mahony
et al., 2009; O'Mahony et al., 2011; Desbonnet et al., 2010). Early
work from Bailey and Coe demonstrated that maternal separation
decreased faecal Lactobacillus in rhesus monkeys 3 days post-
separation (Bailey and Coe, 1999). In rodents, early life maternal
separation disrupts the offspring's microbiota and promotes
colonic hypersensitivity (O'Mahony et al., 2009; O'Mahony et al.,
2011). More recent work by De Palma and colleagues has elabo-
rated upon the role of the gut bacterial commensals in the devel-
opment of behavioural despair using the maternal separation
model (De Palma et al., 2015). In their study, a developmental
history of maternal separation was associated with increased
circulating corticosterone in adult GF mice, but not depressive- or
anxiety-like behaviours. Thus, the presence of gut microbiota may
be unnecessary for the ability of early life maternal separation to
alter stress-related HPA axis activity, but may be necessary to alter
the development of anxiety- and depressive-like behaviours.
Other animal models of chronic stress/depression have been
shown to induce alterations in the microbiota. In rodents, olfactory
bulbectomy produces an array of physiological and behavioural
symptoms with features similar to MDD, including altered neuro-
endocrine and neuroimmune responses. The model also has strong
predictive validity, as the depressive-like behaviours are normal-
ized only after long-term treatment with antidepressant drugs
(Harkin et al., 1999). Interestingly, Park and colleagues demon-
strated that bulbectomy affects gut transit and the composition of
the microbiota by redistributing the relative abundances of bacte-
rial phyla (Park et al., 2013). While these ﬁndings are intriguing, it is
difﬁcult to extrapolate how an altered composition of the gut
microbiota in bulbectomized animals might relate to clinical
depression, or even to other animal models of depression (Dinan
and Cryan, 2013). For example, social defeat stress profoundly al-
ters the operational taxonomic units of the gut microbiota, asso-
ciated with deﬁcits in sociability. A reduction in diversity was
associated with decreases in the abundance of Clostridium species,
as well as decreases in fatty acid production and biosynthesis
pathways leading to dopamine and 5-HT production (Bharwani
et al., 2016). This decrease in Clostridium abundance following so-
cial defeat stress is in contrast to previous work from Bailey and
colleagues, who demonstrated an increase in the relative abun-
dance of Clostridium species following social disruption stress
(Bailey et al., 2011). Despite their considerable differences in
experimental approach, these animal studies collectively highlight
an association between altered gut microbiota and depressive-like
behaviour.
While clinical studies have not yet assessed whether probiotics
or prebiotics are successful in the treatment of MDD, several groups
have documented the beneﬁcial effects of probiotics and prebiotics
in healthy individuals (see Table 1). Indeed, the idea that Lactoba-
cillus strains may improve quality of life and mental health is not
new. Dr. George Porter Phillips ﬁrst reported in 1910 that a gelatin-
whey formula with live lactic acid bacteria improved depressive
symptoms in adults with melancholia (Philips, 1910). More
recently, 3-week supplementation with the prebiotic B-GOS was
found to decrease the cortisol awakening response and to increase
attentional vigilance towards positive stimuli (Schmidt et al., 2015).
This ﬁnding is consistent with those of a functional magnetic
resonance imaging (fMRI) study, which demonstrated that long-
term administration of a probiotic mixture of various Biﬁdobacte-
rium and Lactobacillus species resulted in reduced neural activity
within a widely distributed brain network in response to a task
probing attention towards negative stimuli (Tillisch et al., 2013). A
recent study by Steenbergen and colleagues further demonstrated
the beneﬁcial effects of a Lactobacillus and Biﬁdobacterium mixed
probiotic on mood in healthy individuals (Steenbergen et al., 2015).
Moreover, clinical data from healthy participants suggest that
probiotics are also effective in alleviating behavioural symptoms of
anxiety (Messaoudi et al., 2011a). While the reported effects of
prebiotics and probiotics to improve mood in healthy individuals
lends support to their use in treating depression and anxiety,
carefully controlled clinical trials will be necessary to fully deter-
mine their efﬁcacy in treating depression and anxiety.
6.2. Irritable bowel syndrome (IBS)
Stress, including early life stress, is a key risk factor for IBS, the
most common functional gastrointestinal disorder (Moloney et al.,
2016). IBS is considered to reﬂect pathologically altered gut-brain
axis homeostasis. This disorder is associated with abdominal
visceral pain and altered bowel habits, and is strongly comorbid
with anxiety and depression. Various animal models of visceral
hypersensitivity have been exploited to determine the involvement
of gut microbiota on visceral pain pathways (Larauche et al., 2012;
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Moloney et al., 2015). Assessing visceral sensitivity most often oc-
curs with the use of a balloon inﬂated to speciﬁc pressures using a
barostat (O'Mahony et al., 2012; Ness and Gebhart, 1988). Many of
the preclinical models of increased visceral pain are induced by
applying a psychological or physical stressor that relate to factors
known to predispose to IBS, a clinical disorder characterized by
visceral hypersensitivity to pain (Mayer et al., 2001). Early life stress
or chronic stress later in life are thought to potentiate visceral pain
responses and associated co-morbidities (Moloney et al., 2016).
Antibiotics administered early in life have been shown to induce
long-lasting effects on visceral pain responses, coupled with alter-
ations in pain signaling pathways (O'Mahony et al., 2014). Results
from animal studies of antibiotic-induced dysbiosis demonstrate
that microbiota inﬂuence the wiring of pain pathways early in
development, and that visceral hypersensitivity can persist into
adulthood despite later microbial normalization (O'Mahony et al.,
2014).
Disturbance of the gut microbiota in adult mice also induces
local changes in immune responses and enhanced visceral pain
signaling (Verdu et al., 2006). Studies using GF mice before and
after bacterial colonization indicate that commensal intestinal
microbiota are necessary for the normal excitability of gut sensory
neurons (McVey Neufeld et al., 2013). Furthermore, live luminal
Lactobacillus reuteri (DSM 17938) reduced jejunal spinal nerve
ﬁring evoked by distension or capsaicin (Perez-Burgos et al., 2015).
It has also recently been shown that IBS-like abnormal gut
fermentation and visceral hypersensitivity can be induced in rats
after transplantation of fecal microbiota from constipation-
predominant IBS patients (Crouzet et al., 2013).
The gut microbiota has emerged as an important factor that
potentially contributes to the pathophysiology of IBS (De Palma
et al., 2014; Hyland et al., 2014), despite conﬂicting evidence
regarding the organisation and function of the gut microbiota in
both adult and paediatric patients. In this regard, prolonged
exposure of mice to a high fat diet (HFD) induces low-grade chronic
intestinal inﬂammation, changes the microbiota composition, and
increases bacterial translocation across the intestinal mucosal
barrier (Sun et al., 2016; Gulhane et al., 2016). Further, diets high in
saturated fat are a risk factor for the development of human in-
ﬂammatory bowel diseases, including IBS. Exposure to stress im-
pacts colonicmotor activity, which can alter gutmicrobiota proﬁles,
including lower numbers of potentially beneﬁcial Lactobacillus
Table 1
Clinical and preclinical evidence for the antidepressant and anxiolytic properties associated with targeting the gut microbiota (modiﬁed from reference (Sherwin et al., 2016)).
Behavioural outcomes Physiological outcomes References
Clinical evidence
B-GOS Increased cognitive processing of positive versus
negative attentional vigilance
Reduced cortisol awakening response (Schmidt et al.,
2015)
Lactobacillus casei strain Shirota Reduced anxiety scores in patients with chronic
fatigue syndrome
Increased numbers of Lactobacillus and Biﬁdobacterium in faecal
samples
(Rao et al., 2009)
Improved mood in individuals with a low mood
prior to taking the probiotic
NA (Benton et al.,
2007)
Probiotic formulation:
Lactobacillus helveticus and
Biﬁdobacterium longum
Reduced psychological distress as measured by
the HADS
Reduced 24-h UFC levels (Messaoudi
et al., 2011a)
Multispecies probiotic
formulation: Lactobacillus and
Biﬁdobacterium species
Reduced cognitive processing of sad mood;
decreased aggressive feelings and rumination
NA (Steenbergen
et al., 2015)
Preclinical evidence
Prebiotic- FOS and GOS Antidepressant and anxiolytic-like effects in adult
mice. Reversed the behavioural effects of chronic
psychosocial stress in mice.
Increased BDNF, NR1 and NR2A mRNA, and protein expression in
the dentate gyrus and frontal cortex
Reduced acute and chronic stress-induced corticosterone release.
Modiﬁed speciﬁc gene expression in the hippocampus and
hypothalamus. Reduced chronic stress-induced elevations in pro-
inﬂammatory cytokines levels
(Savignac et al.,
2013; Burokas
et al., 2017)
Prebiotic- 30Sialyllactose and
6'sialyllactose Anxiolytic effect in mice exposed to SDR Prevented SDR-mediated reduction in the number of immature
neurons
(Tarr et al.,
2015)
Prebiotic- GOS & polydextrose
with lactoferrin (Lf) and milk
fat globule membrane
Biﬁdobacterium infantis
Reduced immobility time of maternally separated
rats in a forced swim test
Improves NREM Sleep, Enhance REM Sleep Rebound and Attenuate
the Stress-Induced Decrease in Diurnal Temperature
Attenuated exaggerated IL-6 response in maternally separated rats
following concanavalin A stimulation
(Thompson
et al., 2016)
(Desbonnet
et al., 2010)
Biﬁdobacterium breve Improved depressive and anxiety-related
behaviours in mice
No effect upon circulating corticosterone (Savignac et al.,
2014)
Biﬁdobacterium longum Anxiolytic effect in step-down inhibitory
avoidance
Anxiolytic effect mediated via the vagus nerve (Bercik et al.,
2011b)
Lactobacillus plantarum PS128 Reduced immobility time and increased sucrose
preference in ELS mice
Decreased basal and stress-induced circulating corticosterone
levels; attenuated circulating TNF-a and IL-6 levels while
increasing IL-10 levels in ELS mice
(Liu et al.,
2016b)
Lactobacillus rhamnosus Reduced immobility time in the forced swim test
Decreased stress-induced anxiety-like behaviour
Decreased stress-induced circulating corticosterone secretion and
altered central GABA receptor subunit expression
Attenuated chronic stress-related activation of dendritic cells
while increasing IL-10 þ regulatory T cells
(Bravo et al.,
2011)
(Bharwani et al.,
2017)
Lactobacillus fermentum NS9 Reduced ampicillin-induced anxiety behaviour Decreased ampicillin-induced corticosterone secretion and
increased hippocampal mineralocorticoid receptor and NMDA
receptor levels
(Wang et al.,
2015)
Butyric acid Reduced immobility time in Flinders sensitive line
rats exposed to a forced swim test
Increased BDNF expression within the prefrontal cortex (Wei et al., 2014)
Abbreviations used in Table 1. BDNF brain-derived neurotrophic factor, ELS early life stresseexposed, FOS fructo-oligosaccharide, GABA g-aminobutyric acid, GOS galacto-
oligosaccharide, HADS Hospital Anxiety and Depression Scale, IL interleukin, mRNA messenger RNA, NA not assessed, NMDA N-methyl-d-aspartate, SDR social disruption
stress, TNF tumour necrosis factor, UFC urinary free cortisol, NR NMDA Receptor.
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(Lutgendorff et al., 2008). Thus, stress may interact with diet to
contribute to IBS. Several studies comparing normal controls to IBS
patients have reported decreased proportions of the genera Lacto-
bacillus and Biﬁdobacterium with increased ratios of Firmicutes to
Bacteroidetes at the phylum level (Nagel et al., 2016; Rajilic-
Stojanovic et al., 2011) (for review see (Rajilic-Stojanovic et al.,
2015)). One study indicates that subtypes of IBS patients cluster
with regard to changes in diversity and Firmicutes to Bacteroidetes
ratios compared to healthy controls (Jeffery et al., 2012). This study
is particularly interesting, as it highlights evidence that subtypes of
IBS patients have a relatively “normal”microbiota phenotype while
others display either decreased or increased diversity. Those with
the “normal” microbiota were more likely to display comorbid
depression, which also was associated with deceased intestinal
transit time. This subtype clustering may also be linked to differ-
ential responses to microbiota manipulation. For example, one
study reported that individuals suffering from anxiety and
depression showed improvement of these symptoms after con-
sumption of Lactobacillus and Biﬁdobacteria, whereas other studies
reported a lack of improvement after similar probiotic treatment
(Mayer et al., 2014a; Benton et al., 2007). In a recent systematic
review of speciﬁed probiotics in the management of IBS and other
lower gastrointestinal disorders, an overall beneﬁcial effect of
probiotics was evident in terms of reduced abdominal pain,
bloating, and/or distension in a subset of patients (Hungin et al.,
2013). However, results from clinical trials testing probiotics in
IBS remain difﬁcult to compare, due to widespread differences in
study design, probiotic dose, and probiotic strain (Clarke et al.,
2012). Interestingly there has been some success with the gastro-
intestinal selective antibiotic rifaxamin in treating IBS (Pimentel
et al., 2011). Future studies should also focus on the relationship
between rifaxamin-induced changes in microbiota and stress
responses.
7. High-fat diet, stress, and the gut microbiome
As reviewed in previous sections of this article, the gut-brain
axis exerts a substantial physiological impact on mood, behaviour,
and stress responsiveness. Acute and chronic exposure to stress can
alter both the quality and quantity of calories consumed, and
stress-induced alterations in food intake and energy balance can
interact with emotional state (Epel et al., 2001). In particular,
ingestion of foods rich in fat has been reported to modulate
emotional states in humans and animal models (Ulrich-Lai et al.,
2015). Using the diet-induced obesity (DIO) animal model,
Sharma and Fulton demonstrated that adult C57Bl6 mice
consuming a diet containing 58% of calories as trans-fat for 12
weeks develop depressive-like behaviours, including increased
immobility in the forced swim task and reduced time spent in open
areas of the elevated-plus maze and open ﬁeld tests (Sharma and
Fulton, 2013). These behavioural indices of despair and anxiety
were accompanied by elevated basal HPA activity and increased
corticosterone secretion in response to stress (Wu et al., 2013).
A role for gut microbiota in the long-known link between diet
and emotion has emerged over the past few years, including evi-
dence that high-fat diet feeding promotes a “leaky gut” (i.e.,
increased intestinal permeability (Cani et al., 2008; Hildebrandt
et al., 2009; Kim et al., 2012)), similar to the effect of chronic
stress alone (Gareau et al., 2008; Maes and Leunis, 2008; Ait-
Belgnaoui et al., 2014), and the combination of high-fat diet and
stress exposure may promote even greater bacterial translocation.
In mice, chronic stress combined with a diet high in fat and sugar
has been reported to exacerbate changes in intestinal tight junction
proteins that were associated with altered behaviours and altered
inﬂammatory markers within the hippocampus, with the
hippocampal and behavioural effects shown to be diet-dependent
(de Sousa Rodrigues et al., 2017). A direct link between high-fat
diet, gut microbiota, and behaviour was demonstrated in a recent
study in which microbiota from high-fat fed donor mice were
transferred to chow-fed recipients whose ownmicrobiota had been
depleted by antibiotic treatment (Bruce-Keller et al., 2015).
Intriguingly, transfer of the high-fat-related donormicrobiota led to
increased intestinal permeability and inﬂammatory markers in the
chow-fed recipient mice, accompanied by anxiety-like behaviours
(Bruce-Keller et al., 2015). These results are consistent with a large
literature supporting the view that increased circulating cytokines
subsequent to bacterial translocation can sensitize the HPA axis to
stress-induced activation, and also can increase anxiety- and
depressive-like behaviours (Keightley et al., 2015; Smythies and
Smythies, 2014; Luna and Foster, 2015; Maes et al., 2013).
Conversely, probiotic treatment in mice was found to be sufﬁcient
to prevent the ability of chronic stress to increase intestinal
permeability, and also was sufﬁcient to reduce stress-induced
sympathetic outﬂow and HPA axis activation (Ait-Belgnaoui et al.,
2014). Interestingly, however, high-fat diet exposure does not al-
ways exacerbate the deleterious effects of stress (Ulrich-Lai et al.,
2015). Indeed, one study using mice found that high fat diet
ameliorated the ability of chronic social stress to increase anxiety-
and depressive-like behaviours; in other words, high fat diet had a
selective “protective effect” (Finger et al., 2011). These results
emphasize the complex inﬂuence of dietary factors on stress-
related outcomes, and highlight the need for additional research
to unravel complex interactions and causal relationships among
diet, stress exposure, and the microbial gut-brain axis.
8. Future directions
The concept of psychobiotics, bacteria with positive effects on
mental health, was coined in 2013 (Dinan et al., 2013) and has
recently been expanded to include other microbiota-targeted in-
terventions that can positively modify mental health including in
healthy volunteers (Sarkar et al., 2016). Animal studies have led the
way in showing that speciﬁc strains of Biﬁdobacteria, Lactobacillus
or Bacteroides can have positive effects on brain and behaviour
(Hsiao et al., 2013; Bravo et al., 2011; Bercik et al., 2011b; Savignac
et al., 2014; Savignac et al., 2015), including evidence that certain
bacteria can enhance cognitive processes and affect emotional
learning (Liang et al., 2015; Gareau, 2014; Bravo et al., 2011;
Savignac et al., 2015; Distrutti et al., 2014). However, results from
these studies are only slowly being translated to humans, primarily
through research using healthy volunteers (Tillisch et al., 2013;
Steenbergen et al., 2015; Messaoudi et al., 2011a, 2011b; Kato-
Kataoka et al., 2016). Indeed, recent studies have highlighted the
difﬁculties of translating such responses even within the same
laboratory. Biﬁdobacterium longum 1714 is a bacterium with posi-
tive anti-stress and pro-cognitive effects in an anxiousmouse strain
(Savignac et al., 2014, 2015). Ingestion of this potential psychobiotic
by healthy male volunteers was able to attenuate the increases in
cortisol output and subjective anxiety in response to the socially
evaluated cold pressor test. Furthermore, daily reported stress was
reduced by psychobiotic consumption. Finally subtle improve-
ments in hippocampus-dependent visuospatial memory perfor-
mance, as well as enhanced frontal midline
electroencephalographic mobility were observed following the
consumption of Biﬁdobacteria (Allen et al., 2016). On the other
hand, while Lactobacillus rhamnosus (JB-1) has one of the strongest
preclinical proﬁles of any potential psychobiotic (Bravo et al., 2011),
it had no discernible effect when tested in a similar battery of hu-
man stress and neuropsychology tests as the Biﬁdobacterium lon-
gum (Kelly et al., 1016).
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Over the next few years it is hoped that the mechanisms un-
derpinning the beneﬁcial effects of speciﬁc bacterial strains will be
elucidated. Improved understanding of the developmental impact
of microbiota perturbations on behaviours relevant to stress and
cognitive-related disorders is sorely needed (Desbonnet et al.,
2014; Foster and McVey Neufeld, 2013). Finally, a greater invest-
ment in large-scale clinical trials is needed to determine whether
psychobiotic-based interventions have efﬁcacy in stress-related
disorders. Moreover, the relationship between diet and the
microbiota-gut-brain axis is ripe for exploitation to develop ther-
apeutic strategies for treating stress-related disorders (See Fig. 1).
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